These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1659424)

  • 21. [Membrane and cytoplasmic expression of urokinase-type plasminogen activator receptor in synovial tissues of rheumatoid arthritis patients].
    Zhou JG; Guo XL; Yuan GH; Wei J; Tang Z; Yang MH
    Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):131-4. PubMed ID: 17445440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission.
    Toldi G; Bekő G; Kádár G; Mácsai E; Kovács L; Vásárhelyi B; Balog A
    Clin Chem Lab Med; 2013 Feb; 51(2):327-32. PubMed ID: 22718576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes.
    Kirchheimer JC; Remold HG
    J Immunol; 1989 Oct; 143(8):2634-9. PubMed ID: 2551965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.
    Estreicher A; Mühlhauser J; Carpentier JL; Orci L; Vassalli JD
    J Cell Biol; 1990 Aug; 111(2):783-92. PubMed ID: 2166055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urokinase receptors in human monocytes during angina].
    Krasnikova TL; Parfenova EV; Aref'eva TI; Alekseeva IA; Mukhina SA; Volynskaia EA; Mamontova AG; Liakishev AA
    Biull Eksp Biol Med; 1998 Feb; 125(2):137-9. PubMed ID: 9559120
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression of the plasminogen activation system in kidney cancer correlates with its aggressive phenotype.
    Swiercz R; Wolfe JD; Zaher A; Jankun J
    Clin Cancer Res; 1998 Apr; 4(4):869-77. PubMed ID: 9563880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin G.
    Beaufort N; Leduc D; Rousselle JC; Magdolen V; Luther T; Namane A; Chignard M; Pidard D
    J Immunol; 2004 Jan; 172(1):540-9. PubMed ID: 14688365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes.
    Kirchheimer JC; Nong YH; Remold HG
    J Immunol; 1988 Dec; 141(12):4229-34. PubMed ID: 2848891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
    Stillfried GE; Saunders DN; Ranson M
    Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers.
    Jankun J; Merrick HW; Goldblatt PJ
    J Cell Biochem; 1993 Oct; 53(2):135-44. PubMed ID: 8227186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel, specific pro-urokinase complex on monocyte-like cells, detected by transglutaminase-catalyzed cross-linking.
    Behrendt N; Rønne E; Danø K
    FEBS Lett; 1993 Dec; 336(3):394-6. PubMed ID: 7904248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.
    Carriero MV; Franco P; Del Vecchio S; Massa O; Botti G; D'Aiuto G; Stoppelli MP; Salvatore M
    Cancer Res; 1994 Oct; 54(20):5445-54. PubMed ID: 7923178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheumatoid synovial fibroblasts constitutively express the fibrinolytic pattern of invasive tumor-like cells.
    Guiducci S; Del Rosso A; Cinelli M; Margheri F; D'Alessio S; Fibbi G; Matucci Cerinic M; Del Rosso M
    Clin Exp Rheumatol; 2005; 23(3):364-72. PubMed ID: 15971425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urokinase-mediated fibrinolysis in the synovial fluid of rheumatoid arthritis patients may be affected by the inactivation of single chain urokinase type plasminogen activator by thrombin.
    Braat EA; Jie AF; Ronday HK; Beekman B; Rijken DC
    Ann Rheum Dis; 2000 Apr; 59(4):315-8. PubMed ID: 10733483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
    Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
    Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urokinase does not effect the tissue factor mediated monocyte pro-coagulant activity].
    Aref'eva TI; Krasnikova TL
    Ross Fiziol Zh Im I M Sechenova; 2000 Oct; 86(10):1308-13. PubMed ID: 11200332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte-expressed urokinase regulates human vascular smooth muscle cell migration in a coculture model.
    Kusch A; Tkachuk S; Lutter S; Haller H; Dietz R; Lipp M; Dumler I
    Biol Chem; 2002 Jan; 383(1):217-21. PubMed ID: 11928816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of urokinase plasminogen activator, its receptor and plasminogen activator inhibitor type 1 in different types of atherosclerotic lesion in human aorta].
    Solomatina MA; Plekhanova OS; Il'inskaia OP; Kalinina NI; Mikhaĭlova EV; Tsokolaeva ZI; Tararak EM; Naumov VG; Parfenova EV
    Tsitologiia; 2004; 46(4):352-60. PubMed ID: 15346794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urokinase-type plasminogen-activator receptor associates to a cell surface molecule in monocytic cells.
    Ragno P; Montuori N; Rossi G
    Biochem Biophys Res Commun; 1996 Jul; 224(1):252-7. PubMed ID: 8694822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptor.
    Casslén B; Nordengren J; Gustavsson B; Nilbert M; Lund LR
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2776-84. PubMed ID: 7673423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.